World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
37963
World Ranking
7078
National Ranking
3722

Gregory N. Fuller publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gregory N. Fuller sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 513 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gregory N. Fuller D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gregory N. Fuller sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gregory N. Fuller is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research focuses primarily on the field of medicine, with significant contributions in genetics, epidemiology, neurology, pulmonary and respiratory medicine, as well as radiology, nuclear medicine, and imaging.

The scientist has a substantial body of work related to glioma diagnosis and treatment, meningioma and schwannoma management, brain metastases and treatment, neuroblastoma research and treatments, radiomics and machine learning in medical imaging, neurofibromatosis and schwannoma cases, and mechanisms of neuroinflammation and neurodegeneration.

Frequent coauthors with whom Gregory N. Fuller has collaborated include:

  • Amy B. Heimberger
  • Wafik Zaky
  • Sujit S. Prabhu
  • Jeffrey S. Weinberg
  • Frederick F. Lang

The scientist's prominent publication venues consist of:

  • Neuro-Oncology
  • Neuro-Oncology Advances
  • American Journal of Neuroradiology
  • Oncogene
  • Clinical Cancer Research

Among the recent papers featuring Gregory N. Fuller's contributions are:

  • "cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading" (2020) published in Brain Pathology
  • "cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas" (2020) published in Acta Neuropathologica
  • "IGFBP2: integrative hub of developmental and oncogenic signaling network" (2020) published in Oncogene
  • "Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons" (2024) published in Clinical Infectious Diseases
  • "Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells" (2020) published in Clinical Cancer Research

Best Publications

  • Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

    Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung

  • Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice

    Eric C. Holland;Joseph Celestino;Chengkai Dai;Laura Schaefer

  • Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

    Ashok J Kumar;N. E. Leeds;Gregory N Fuller;P. Van Tassel

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • PD-L1 expression and prognostic impact in glioblastoma.

    Edjah K. Nduom;Jun Wei;Nasser K. Yaghi;Neal Huang

  • Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

    Frederick F Lang;Charles Conrad;Candelaria Gomez-Manzano;W K Alfred Yung

  • Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.

    John F. de Groot;Gregory N. Fuller;Ashok J. Kumar;Yuji Piao

  • Limitations of stereotactic biopsy in the initial management of gliomas

    Robert J. Jackson;Gregory N. Fuller;Dima Abi-Said;Frederick F. Lang

  • Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results

    Frederick F. Lang;Janet M. Bruner;Gregory N. Fuller;Kenneth Aldape

  • Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

    Konrad Gabrusiewicz;Benjamin Rodriguez;Jun Wei;Yuuri Hashimoto

  • Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

    Peter A. Humphrey;Albert J. Wong;Bert Vogelstein;Michael R. Zalutsky

  • Sacral chordoma: 40-year experience at a major cancer center.

    Julie E. York;Adriana Kaczaraj;Dima Abi-Said;Gregory N. Fuller

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

    David N. Louis;Pieter Wesseling;Kenneth Aldape;Daniel J. Brat

  • A Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal Tumors

    Lei L. Chen;Jonathan C. Trent;Elsie F. Wu;Gregory N. Fuller

  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

    Daniel J. Brat;Kenneth Aldape;Howard Colman;Dominique Figrarella-Branger

  • Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

    Juan Fueyo;Ramon Alemany;Candelaria Gomez-Manzano;Gregory N. Fuller

  • Differential Expression of Membrane-Type Matrix Metalloproteinase and Its Correlation with Gelatinase A Activation in Human Malignant Brain Tumors in Vivo and in Vitro

    Masaaki Yamamoto;Sanjeeva Mohanam;Raymond Sawaya;Gregory N. Fuller

  • Ink4a-Arf Loss Cooperates with KRas Activation in Astrocytes and Neural Progenitors to Generate Glioblastomas of Various Morphologies Depending on Activated Akt

    Lene Uhrbom;Chengkai Dai;Joseph C. Celestino;Marc K. Rosenblum

  • Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

    Amy B. Heimberger;Mohamed Abou-Ghazal;Chantal Reina-Ortiz;David S. Yang

  • Pathology and Genetics of Tumours of the Nervous System (World Health Organization Classification of Tumours).

    Gregory N. Fuller

Frequent Co-Authors

Raymond Sawaya
Raymond Sawaya The University of Texas MD Anderson Cancer Center
Frederick F. Lang
Frederick F. Lang The University of Texas MD Anderson Cancer Center
wei zhang
wei zhang Wake Forest University
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
Kenneth R. Hess
Kenneth R. Hess The University of Texas MD Anderson Cancer Center
Jason T. Huse
Jason T. Huse The University of Texas MD Anderson Cancer Center
Waldemar Priebe
Waldemar Priebe The University of Texas MD Anderson Cancer Center
Eric C. Holland
Eric C. Holland Fred Hutchinson Cancer Research Center
Huamin Wang
Huamin Wang The University of Texas MD Anderson Cancer Center
Ashok Kumar
Ashok Kumar University of Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in a medical career but want alternative routes or more flexibility, numerous online degree options may be right for you. Online programs allow working professionals and those with life commitments to advance their education from anywhere.

For those considering advanced practice, online nurse practitioner programs offer a pathway to specialized roles and increased responsibilities in the healthcare setting. Meanwhile, students seeking an affordable entry into the nursing profession can explore the cheapest online nursing program options that combine quality with cost efficiency.

Experienced nurses looking to take on leadership, research, or education roles may choose to pursue online PhD nursing programs, which provide the academic depth needed for upper-level positions. Additionally, registered nurses aiming to boost their credentials and earning potential should look at the cheapest online BSN programs, designed to help them achieve a bachelor’s degree in nursing.

Exploring these flexible, accredited programs can help you discover new career pathways in medicine while accommodating your unique schedule and budget.

Best Scientists Citing Gregory N. Fuller

Trending Scientists

Recently Published Articles